Aegerion Pharmaceuticals Inc. (AEGR): Broadfin Capital Raises Its Stake Ahead of Merger
Back in June, Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR), Qlt Inc. and the latter’s subsidiary, Isotope Acquisition Corp., entered into an Agreement...
Posts Tagged ‘Aegerion Pharmaceuticals Inc. (AEGR)’
Why Aegerion Pharmaceuticals, Bank of America and Three Other Stocks are in Spotlight Today?
Markets opened higher on Wednesday as investors await the announcement regarding interest rate hike from the Federal Reserve today. Analysts think that...
Pharmaceutical And LNG Stocks Are Driving The Market Higher Today
U.S. stocks look set to end today’s trading session in green territory, having gone through a strong selloff last week. Among them there are several...
These Four Stocks Are Leading Today’s Losers Pack for Various Reasons
Although the market has regained most of the losses from the opening hour, there are some stocks that have remained deep in red. Valeant Pharmaceuticals...
One Fund is Buying This Biotech Stock Although It’s Losing Smart Money’s Support
Alex Denner is still bullish on Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) and has further increased his stake in the company. As reported in a recent...
Broadfin Capital Thinks ContraFect Corp (CFRX) Can Prevent 25% of Deaths
According to a recent 13G form filed with the Securities and Exchange Commission, Kevin Kotler‘s Broadfin Capital has initiated a stake in ContraFect...
Carbylan Therapeutics Inc (CBYL): Broadfin’s Latest Move and Market Smashing Q1 Returns Inside
To say Kevin Kotler’s Broadfin Capital had exceptional Q1 returns from its 11 long positions in companies valued at $1 billion or more would be a gross...
Aegerion Pharmaceuticals, Inc. (AEGR), Joint Corp (JYNT), Trillium Therapeutics Inc. (TRIL): Latest Fund Moves in the Hot Healthcare Sector
At Insider Monkey, we track over 700 of the top hedge funds in the world, following and reporting on their latest moves disclosed through filings with...
Aegerion Pharmaceuticals, Inc. (AEGR): Broadfin Boosts Stake Getting on Board with Other Bullish Investors
Kevin Kotler‘s New York-based fund Broadfin Capital has boosted its position in Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR). In a new filing with...
Lumber Liquidators Holdings Inc (LL): Steve Cohen’s Point72 Seems To Love This Stock
Steve Cohen’s Point72 Asset Management disclosed today a huge increase in its stake in Lumber Liquidators Holdings Inc (NYSE:LL). The funds affiliated...
Aegerion Pharmaceuticals Inc. (AEGR), Cytori Therapeutics Inc (CYTX): Scopia Capital and Sabby Capital Are Bullish on These Stocks
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) continues to feel hedge funds’ bullishness. Not only did Steve Cohen’s Point72 Asset Management disclose...
Aegerion Pharmaceuticals, Inc. (AEGR): Steve Cohen’s Point72 Asset Management Goes Big
Life science is turning out to be an industry sector that most hedgies are convinced will outperform in the near future. In the last few days we have...
Aegerion Pharmaceuticals, Inc. (AEGR) & The GEO Group Inc (GEO): Scopia Capital Bets On Biotech Recovery, Gets Out Of Real Estate
Scopia Capital Management has disclosed in a recent regulatory filing with the Security and Exchange Commission that it has acquired 4.2 million shares...
Two Healthcare Stocks That Insiders Are Buying
Over the past couple of days, the healthcare sector has witnessed plenty of insider activity, which should not be overlooked. In this article, I will...
Four Reasons to Buy This Biotechnology Stock
ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS), a developer and marketer of RNA-based novel drugs to treat a variety of diseases, has been one of the best...
Aegerion Pharmaceuticals, Inc. (AEGR), Rigel Pharmaceuticals, Inc. (RIGL), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): The Rise of Little Pharma
Big Pharma gets plenty of hype. But is Little Pharma where investors can make the biggest gains? The answer to that question is a resounding “yes...
Is Pacira Pharmaceuticals Inc (PCRX) Going to Burn These Hedge Funds?
Should Pacira Pharmaceuticals Inc (NASDAQ:PCRX) investors track the following data? To the average investor, there are many methods market participants...
Alexion Pharmaceuticals, Inc. (ALXN), Pharmacyclics, Inc. (PCYC), Aegerion Pharmaceuticals, Inc. (AEGR), Raptor Pharmaceutical Corp. (RPTP): Have These Four Biotechs Peaked?
Biotechnology stocks often trade with excessive valuations, until one day, large losses occur. The best way to protect yourself is to be logical when...
Aegerion Pharmaceuticals, Inc. (AEGR): Cheers and Jeers for Amgen, Inc. (AMGN)’s Pipeline
Just after the successful acquisition of Onyx Pharmaceuticals and positive results on AMG-145, a cholesterol-lowering experimental drug, Amgen, Inc...
ISIS Pharmaceuticals, Inc. (ISIS) Scores Another Big Biotech Deal With Biogen Idec Inc. (BIIB)
Make that four collaborations between Biogen Idec Inc. (NASDAQ:BIIB) and ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) in the last two years. The pair announced...
Hedge Funds Are Buying Impax Laboratories Inc (IPXL)
Is Impax Laboratories Inc (NASDAQ:IPXL) a good investment? At the moment, there are tons of indicators shareholders can use to analyze publicly traded...
Santarus, Inc. (SNTS), Aegerion Pharmaceuticals, Inc. (AEGR), Ariad Pharmaceuticals, Inc. (ARIA): Did a Strong New Drug Make This Biotech Overvalued?
Santarus, Inc. (NASDAQ:SNTS) has risen over 300% in the past year partly based on sales optimism for ulcerative colitis drug Uceris, which launched in...
Is Aegerion Pharmaceuticals, Inc. (AEGR) Going to Burn These Hedge Funds?
To the average investor, there are dozens of gauges market participants can use to watch publicly traded companies. Some of the most under-the-radar are...
Aegerion Pharmaceuticals, Inc. (AEGR), ISIS Pharmaceuticals, Inc. (ISIS), Sanofi SA (ADR) (SNY): This Is One Incredible CEO
The Motley Fool’s readers have spoken, and I have heeded their cries. After months of pointing out CEO gaffes and faux pas, I’ve decided...
Questcor Pharmaceuticals Inc (QCOR), ISIS Pharmaceuticals, Inc. (ISIS): Despite a Mid-Stage Disappointment, This Biotech Stock Is Still in Great Shape
As human beings it can sometimes be difficult for us to see the good in a bad situation. In the biotech sector, where developing a drug can cost hundreds...
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK), Aegerion Pharmaceuticals, Inc. (AEGR): Will This Speculative Cholesterol Treatment Pay Off?
In America, 33.5% of adults over the age of 20 have high LDL (“bad”) cholesterol levels, according to the CDC. Even though the American Heart Association...
ISIS Pharmaceuticals, Inc. (ISIS), Aegerion Pharmaceuticals, Inc. (AEGR): Two Drugs Competing for an One-In-A-Million Disease
Both ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) and Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) have a single drug in the market that help heart patients...
Alexion Pharmaceuticals, Inc. (ALXN), BioMarin Pharmaceutical Inc. (BMRN): 5 of the World’s Most Ultra-Rare Diseases
There are few times when your doctor or physician will utter the phrase, “I don’t know” to a patient, but when you’re dealing...
Aegerion Pharmaceuticals, Inc. (AEGR), ISIS Pharmaceuticals, Inc. (ISIS), BioMarin Pharmaceutical Inc. (BMRN): Orphan Drug Makers – Robust Investment Opportunities
The US pharmaceutical industry has been revolutionized by the emerging biotech companies which have discovered new ways to cure even the rarest of diseases...
Aegerion Pharmaceuticals, Inc. (AEGR), Mosaic Co (MOS), Staples, Inc. (SPLS): 3 Stocks to Get on Your Watchlist
I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated. Without my watchlist, I’d be unable to keep up on...
Aegerion Pharmaceuticals, Inc. (AEGR), NPS Pharmaceuticals, Inc. (NPSP): Three of the World’s Rarest Diseases (and the Uncommon Profits They Bring)
Imagine finding out that you have a disease that only a handful of people around the world have. Kirstie and Catherine Fields don’t have to imagine...
ISIS Pharmaceuticals, Inc. (ISIS): This Anti-Sense Bet Makes Sense
In the last couple of years, the biotechnology industry has been on a roll. The large number of drug approvals and the dreaded patent cliff has positively...
VIVUS, Inc. (VVUS), ISIS Pharmaceuticals, Inc. (ISIS), Gilead Sciences, Inc. (GILD): Biotech Companies Battle It Out
Biotech companies sometimes get lucky, launching a drug into a new indication where there’s no competition, but more often than not the biotech...
Aegerion Pharmaceuticals, Inc. (AEGR), Arena Pharmaceuticals, Inc. (ARNA): Investment Opportunities in Drug Launches
There are investment opportunities in every sector, but biotechs launching new drugs offer a unique investment opportunity to take advantage of hyper-...
Here is What Hedge Funds Think About Pacira Pharmaceuticals Inc (PCRX)
Is Pacira Pharmaceuticals Inc (NASDAQ:PCRX) a superb investment right now? Hedge funds are in an optimistic mood. The number of long hedge fund positions...
Arena Pharmaceuticals, Inc. (ARNA), Rigel Pharmaceuticals, Inc. (RIGL): This Week in Biotech
With the SPDR S&P Biotech Index up 38% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the...
Aegerion Pharmaceuticals, Inc. (AEGR), MannKind Corporation (MNKD): 3 Biotech Companies You Should Have Bought This Year
Biotech companies can make you rich if you buy the right ones at the right time. They can also make you poor; but let’s not dwell on the negative...
Aegerion Pharmaceuticals, Inc. (AEGR): A $90 Price Target for This Biotech! How’s It Figured?
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) is currently trading higher by 13% after having its price target raised to $90 by Canaccord – which is...
Why Aegerion Pharmaceuticals, Inc. (AEGR) Shares Jumped
Although we don’t believe in timing the market or panicking over market movements, we do like to keep an eye on big changes — just in case...
Hedge Funds Are Crazy About Aegerion Pharmaceuticals, Inc. (AEGR)
Is Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) a good stock to buy now? Hedge funds are getting more bullish. The number of long hedge fund bets improved...
Aegerion Pharmaceuticals, Inc. (AEGR), TESARO Inc (TSRO), And Three Humongous Healthcare Stocks This Week
Up, up, and away. That’s the motto for the market as a whole so far this year, but it’s also especially applicable for a select group of stocks...
Is Aegerion Pharmaceuticals, Inc. (AEGR) Now a Sell?
Shares of Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) rallied an incredible 31.37% on Thursday after a series of bullish notes that painted a clearer...
What Do Tesla Motors Inc (TSLA) And Netflix, Inc. (NFLX) Have In Common?
The U.S. Producer Price Index signaled deflation in April, industrial production dipped 0.5%, and eurozone GDP clocked in at a worse-than-expected 0.2...
Regeneron Pharmaceuticals Inc (REGN), Questcor Pharmaceuticals Inc (QCOR), Aegerion Pharmaceuticals, Inc. (AEGR): Three Booming Biotech Companies
Wall Street had a great week. The Dow topped 15,000. The S&P 500 also notched a record high. But few stocks blew the doors off like those of these...
Amgen, Inc. (AMGN): What’s Its Next Catalyst?
Amgen, Inc. (NASDAQ:AMGN) stock has been on a bit of a roller coaster lately. Shares are up 23% year to date, but 8% off the high set earlier this month...
Aegerion Pharmaceuticals, Inc. (AEGR), Raptor Pharmaceutical Corp. (RPTP): Two Orphan Drugmakers With Upcoming Catalysts
Within the next few days, stocks for two orphan drugmakers could either soar or sink. Both Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) and Raptor Pharmaceutical...
Sanofi SA (ADR) (SNY), Aegerion Pharmaceuticals, Inc. (AEGR): ISIS Pharmaceuticals, Inc. (ISIS), Big Pharma’s Little Friend
Roche Holding Ltd. (ADR) (PINK:RHHBY) and ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) announced Monday a new partnership for developing treatments for Huntington...
Aegerion Pharmaceuticals, Inc. (AEGR), Dole Food Company, Inc. (DOLE) & More: 3 Companies Insiders Love
An interesting method of assessing the direction a stock can take is by monitoring insider purchases. This is because company insiders hold information...
Can’t-Miss Health-Care Events This Week: GlaxoSmithKline plc (ADR)(GSK), Theravance Inc (THRX)
With no PDUFA decisions on the plate this week, we’ll instead turn our attention to two important FDA panel meetings and two earnings reports that...
4 Orphan Drugs Making Waves in 2013: Sanofi SA (ADR) (SNY) and More
Orphan drugs — medications meant for small patient populations with rare, dangerous diseases — can be a rewarding business for biotech firms...
